Oligonucleotides comprising a C5-modified pyrimidine

Details for Australian Patent Application No. 2005323437 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Rajeev, Kallanthottathil G.; Manoharan, Muthiah

Agent Griffith Hack

Pub. Number AU-B-2005323437

PCT Pub. Number WO2006/073458

Priority 60/620,276 20.10.04 US; 60/566,710 30.04.04 US

Filing date 29 April 2005

Wipo publication date 13 July 2006

Acceptance publication date 6 October 2011

International Classifications

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2006/073458 Priority application(s): WO2006/073458

19 June 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 07 May 2008 2006

6 October 2011 Application Accepted

  Published as AU-B-2005323437

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323439-Preparation of fibers from a supported array of nanotubes

2005323436-Bioactive compounds and methods of uses thereof